Investigator Biography

Cheril Clarson, MRCP(UK), FRCP(C)

Dr. Clarson is Section Head of Pediatric Endocrinology at the Children’s Hospital, London Health Sciences Centre, Associate Professor at the University of Western Ontario and an Associate Scientist at the Lawson Health Research Institute. She heads a regional diabetes outreach program extending throughout Southwestern Ontario, committed to fostering collaboration and cooperation between the tertiary centre and community based health care professionals and providing care to over 700 children with diabetes. In addition to providing clinical care, this program disseminates current clinical practice guidelines and fosters collaboration and cooperation between the tertiary centre and community based health care professionals.

She is the pediatric site investigator for the Trial to Reduce Insulin-dependent diabetes in the Genetically at Risk (TRIGR) and has recruited subjects for TrialNet Natural History Study of Type 1 Diabetes and The Diabetes Prevention Trial Type 1 (DPT-1).

During the last five years, Dr. Clarson has collaborated with community partners as well as investigators at the Lawson Health Research Institute and the Faculty of Health Sciences, University of Western Ontario in developing a network dedicated to pediatric obesity research. She founded the HIP Kids Multidisciplinary Overweight and Obesity program committed to translating this research to clinical care.

Dr. Clarson is a representative for the Lawson Wilkins Pediatric Endocrine Society (LWPES) Drugs and Therapeutics Committee. Between 2006 and 2010, Dr. Clarson served as a Councillor, Clinical & Scientific Section, Executive Committee, Canadian Diabetes Association (CDA), and as a member of the CDA National Advocacy Council. Dr. Clarson was president of the Canadian Pediatric Endocrine Group (CPEG) from 2007 to 2009, and chaired the Organizing and Scientific Committee for the 2007 Scientific Meeting which was held in London, Ontario. Dr. Clarson also participated on the 2003 Clinical Practice Guidelines Committee and the Network of Ontario Pediatric Diabetes program.

Lets turn type one into type none